学会発表（国際）
A phase II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese study group of adjuvant therapy for pancreatic cancer (JSAP-03).
Saiura A, Ueno H, Kosuge T, Matsuyama Y, Ishii H, Nakao A, Doi R, Tanaka M. A phase II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese study group of adjuvant therapy for pancreatic cancer (JSAP-03). ASCO 2012 Gastrointestinal Cancers Symposium (January 19 - 21, 2012). Abstract #88144